PVL-Staphylococcus aureus infections: diagnosis and management for primary care

Guidance for diagnosing and managing Panton-Valentine Leukocidin (PVL)-associated Staphylococcus aureus infections in primary care settings.

This publication was withdrawn on

This quick reference guide is based on out of date PVL HPA guidance which is not planned to be updated. See Primary care guidance: diagnosing and managing infections.


Diagnosis and management of Panton-Valentine Leukocidin (PVL)-Staphylococcus aureus infections: quick reference guide for primary care

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


Panton-Valentine Leukocidin (PVL)-Staphylococcus aureus (PVL-SA) cause recurrent skin and soft tissue infections, but can also cause invasive infections, including necrotising haemorrhagic pneumonia in otherwise healthy young people in the community.

Published 18 May 2008